The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer

During a two year period, 65 patients with Stage II non-seminomatous testis cancer were randomized to receive adjuvant chemotherapy and radiation. Of the 52 evaluable patients, 23 received radiation followed by chemotherapy (sequential), and 29 received the same chemotherapy as initial treatment, bu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int. J. Radiat. Oncol., Biol. Phys.; (United States) Biol. Phys.; (United States), 1983-12, Vol.9 (12), p.1885-1890
Hauptverfasser: Stephens, Ronald L., Eltringham, James R., Coltman, Charles A., Neidhart, James, Mullins, James, Frank, Jess
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1890
container_issue 12
container_start_page 1885
container_title Int. J. Radiat. Oncol., Biol. Phys.; (United States)
container_volume 9
creator Stephens, Ronald L.
Eltringham, James R.
Coltman, Charles A.
Neidhart, James
Mullins, James
Frank, Jess
description During a two year period, 65 patients with Stage II non-seminomatous testis cancer were randomized to receive adjuvant chemotherapy and radiation. Of the 52 evaluable patients, 23 received radiation followed by chemotherapy (sequential), and 29 received the same chemotherapy as initial treatment, but had drug treatment temporarily interrupted for radiation (sandwich). The combined treatment was well tolerated, but did not eliminate recurrence. With regard to duration of survival and disease-free survival, no statistically significant difference could be found between the sequential and sandwich approaches.
doi_str_mv 10.1016/0360-3016(83)90357-7
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_miscellaneous_80848182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0360301683903577</els_id><sourcerecordid>80848182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-f9a8ae9ea8458b6aeddcb15fabd4c65883aa563f3e62f04dc7db03f60b17d0e23</originalsourceid><addsrcrecordid>eNp9kc2LFDEQxYMo67j6HygEEdFDa2XSH2kPgi5-DCx4WcFbqE6qZ3rpSXqT9Or896adYY6eEqhfPV69x9hzAe8EiPo9yBoKmX9vlHzbgqyaonnAVkI1bSGr6tdDtjojj9mTGG8BQIimvGAXtWiVFHLFppsd8ejntPtNMXHvjB_99sC3wc8Tpz8ThYGcoQ8c7e18jy7xtKOA04H3PvCYcEt885mjs3yz4c67ItJ-cH6Pyc-Rp6w6mHnEwA1mnfCUPepxjPTs9F6yn1-_3Fx9L65_fNtcfboujFyrVPQtKqSWUJWV6moka00nqh47W5q6UkoiVrXsJdXrHkprGtuB7GvoRGOB1vKSvTzq-mxARzMkMjvjnSOTdAUCSgUZen2EpuDv5mxV74doaBzRUXavFahSCbWolUfQBB9joF5PYdhjOGgBemlDL1HrJWqtpP7Xhm7y2ouT_tztyZ6XTvHn-avTHKPBsQ85oiGesbYBKKHM2McjRjmw-4HCcs_Sih3Cco71w_99_AXlqafW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80848182</pqid></control><display><type>article</type><title>The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Stephens, Ronald L. ; Eltringham, James R. ; Coltman, Charles A. ; Neidhart, James ; Mullins, James ; Frank, Jess</creator><creatorcontrib>Stephens, Ronald L. ; Eltringham, James R. ; Coltman, Charles A. ; Neidhart, James ; Mullins, James ; Frank, Jess ; Univ. of Kansas, Kansas City</creatorcontrib><description>During a two year period, 65 patients with Stage II non-seminomatous testis cancer were randomized to receive adjuvant chemotherapy and radiation. Of the 52 evaluable patients, 23 received radiation followed by chemotherapy (sequential), and 29 received the same chemotherapy as initial treatment, but had drug treatment temporarily interrupted for radiation (sandwich). The combined treatment was well tolerated, but did not eliminate recurrence. With regard to duration of survival and disease-free survival, no statistically significant difference could be found between the sequential and sandwich approaches.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/0360-3016(83)90357-7</identifier><identifier>PMID: 6198313</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>550603 - Medicine- External Radiation in Therapy- (1980-) ; 560151 - Radiation Effects on Animals- Man ; Adjuvant treatment ; Adult ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; BETA DECAY RADIOISOTOPES ; BETA-MINUS DECAY RADIOISOTOPES ; Biological and medical sciences ; Bleomycin - administration &amp; dosage ; BODY ; CHEMOTHERAPY ; COBALT 60 ; COBALT ISOTOPES ; Combined Modality Therapy ; DISEASES ; ELECTROMAGNETIC RADIATION ; GAMMA RADIATION ; GONADS ; Gynecology. Andrology. Obstetrics ; HARD X RADIATION ; HEMIC DISEASES ; Humans ; INTERMEDIATE MASS NUCLEI ; INTERNAL CONVERSION RADIOISOTOPES ; IONIZING RADIATIONS ; ISOMERIC TRANSITION ISOTOPES ; ISOTOPES ; LEUKOPENIA ; Male ; Male genital diseases ; MALE GENITALS ; Medical sciences ; MEDICINE ; Middle Aged ; MINUTES LIVING RADIOISOTOPES ; Neoplasm Recurrence, Local - epidemiology ; Neoplasm Recurrence, Local - therapy ; Neoplasm Staging ; NEOPLASMS ; NUCLEAR MEDICINE ; NUCLEI ; ODD-ODD NUCLEI ; ORGANS ; PATIENTS ; RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT ; RADIATIONS ; RADIOINDUCTION ; RADIOISOTOPES ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOTHERAPY ; Radiotherapy Dosage ; Random Allocation ; SIDE EFFECTS ; TESTES ; Testicular Neoplasms - mortality ; Testicular Neoplasms - pathology ; Testicular Neoplasms - therapy ; Testis cancer ; THERAPY ; Time Factors ; Tumors ; United States ; Vinblastine - administration &amp; dosage ; X RADIATION ; YEARS LIVING RADIOISOTOPES</subject><ispartof>Int. J. Radiat. Oncol., Biol. Phys.; (United States), 1983-12, Vol.9 (12), p.1885-1890</ispartof><rights>1983</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c328t-f9a8ae9ea8458b6aeddcb15fabd4c65883aa563f3e62f04dc7db03f60b17d0e23</citedby><cites>FETCH-LOGICAL-c328t-f9a8ae9ea8458b6aeddcb15fabd4c65883aa563f3e62f04dc7db03f60b17d0e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0360-3016(83)90357-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,883,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9700404$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6198313$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/5010480$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Stephens, Ronald L.</creatorcontrib><creatorcontrib>Eltringham, James R.</creatorcontrib><creatorcontrib>Coltman, Charles A.</creatorcontrib><creatorcontrib>Neidhart, James</creatorcontrib><creatorcontrib>Mullins, James</creatorcontrib><creatorcontrib>Frank, Jess</creatorcontrib><creatorcontrib>Univ. of Kansas, Kansas City</creatorcontrib><title>The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer</title><title>Int. J. Radiat. Oncol., Biol. Phys.; (United States)</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>During a two year period, 65 patients with Stage II non-seminomatous testis cancer were randomized to receive adjuvant chemotherapy and radiation. Of the 52 evaluable patients, 23 received radiation followed by chemotherapy (sequential), and 29 received the same chemotherapy as initial treatment, but had drug treatment temporarily interrupted for radiation (sandwich). The combined treatment was well tolerated, but did not eliminate recurrence. With regard to duration of survival and disease-free survival, no statistically significant difference could be found between the sequential and sandwich approaches.</description><subject>550603 - Medicine- External Radiation in Therapy- (1980-)</subject><subject>560151 - Radiation Effects on Animals- Man</subject><subject>Adjuvant treatment</subject><subject>Adult</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>BETA-MINUS DECAY RADIOISOTOPES</subject><subject>Biological and medical sciences</subject><subject>Bleomycin - administration &amp; dosage</subject><subject>BODY</subject><subject>CHEMOTHERAPY</subject><subject>COBALT 60</subject><subject>COBALT ISOTOPES</subject><subject>Combined Modality Therapy</subject><subject>DISEASES</subject><subject>ELECTROMAGNETIC RADIATION</subject><subject>GAMMA RADIATION</subject><subject>GONADS</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>HARD X RADIATION</subject><subject>HEMIC DISEASES</subject><subject>Humans</subject><subject>INTERMEDIATE MASS NUCLEI</subject><subject>INTERNAL CONVERSION RADIOISOTOPES</subject><subject>IONIZING RADIATIONS</subject><subject>ISOMERIC TRANSITION ISOTOPES</subject><subject>ISOTOPES</subject><subject>LEUKOPENIA</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>MALE GENITALS</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>MINUTES LIVING RADIOISOTOPES</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Neoplasm Staging</subject><subject>NEOPLASMS</subject><subject>NUCLEAR MEDICINE</subject><subject>NUCLEI</subject><subject>ODD-ODD NUCLEI</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</subject><subject>RADIATIONS</subject><subject>RADIOINDUCTION</subject><subject>RADIOISOTOPES</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOTHERAPY</subject><subject>Radiotherapy Dosage</subject><subject>Random Allocation</subject><subject>SIDE EFFECTS</subject><subject>TESTES</subject><subject>Testicular Neoplasms - mortality</subject><subject>Testicular Neoplasms - pathology</subject><subject>Testicular Neoplasms - therapy</subject><subject>Testis cancer</subject><subject>THERAPY</subject><subject>Time Factors</subject><subject>Tumors</subject><subject>United States</subject><subject>Vinblastine - administration &amp; dosage</subject><subject>X RADIATION</subject><subject>YEARS LIVING RADIOISOTOPES</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2LFDEQxYMo67j6HygEEdFDa2XSH2kPgi5-DCx4WcFbqE6qZ3rpSXqT9Or896adYY6eEqhfPV69x9hzAe8EiPo9yBoKmX9vlHzbgqyaonnAVkI1bSGr6tdDtjojj9mTGG8BQIimvGAXtWiVFHLFppsd8ejntPtNMXHvjB_99sC3wc8Tpz8ThYGcoQ8c7e18jy7xtKOA04H3PvCYcEt885mjs3yz4c67ItJ-cH6Pyc-Rp6w6mHnEwA1mnfCUPepxjPTs9F6yn1-_3Fx9L65_fNtcfboujFyrVPQtKqSWUJWV6moka00nqh47W5q6UkoiVrXsJdXrHkprGtuB7GvoRGOB1vKSvTzq-mxARzMkMjvjnSOTdAUCSgUZen2EpuDv5mxV74doaBzRUXavFahSCbWolUfQBB9joF5PYdhjOGgBemlDL1HrJWqtpP7Xhm7y2ouT_tztyZ6XTvHn-avTHKPBsQ85oiGesbYBKKHM2McjRjmw-4HCcs_Sih3Cco71w_99_AXlqafW</recordid><startdate>198312</startdate><enddate>198312</enddate><creator>Stephens, Ronald L.</creator><creator>Eltringham, James R.</creator><creator>Coltman, Charles A.</creator><creator>Neidhart, James</creator><creator>Mullins, James</creator><creator>Frank, Jess</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>198312</creationdate><title>The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer</title><author>Stephens, Ronald L. ; Eltringham, James R. ; Coltman, Charles A. ; Neidhart, James ; Mullins, James ; Frank, Jess</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-f9a8ae9ea8458b6aeddcb15fabd4c65883aa563f3e62f04dc7db03f60b17d0e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>550603 - Medicine- External Radiation in Therapy- (1980-)</topic><topic>560151 - Radiation Effects on Animals- Man</topic><topic>Adjuvant treatment</topic><topic>Adult</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>BETA-MINUS DECAY RADIOISOTOPES</topic><topic>Biological and medical sciences</topic><topic>Bleomycin - administration &amp; dosage</topic><topic>BODY</topic><topic>CHEMOTHERAPY</topic><topic>COBALT 60</topic><topic>COBALT ISOTOPES</topic><topic>Combined Modality Therapy</topic><topic>DISEASES</topic><topic>ELECTROMAGNETIC RADIATION</topic><topic>GAMMA RADIATION</topic><topic>GONADS</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>HARD X RADIATION</topic><topic>HEMIC DISEASES</topic><topic>Humans</topic><topic>INTERMEDIATE MASS NUCLEI</topic><topic>INTERNAL CONVERSION RADIOISOTOPES</topic><topic>IONIZING RADIATIONS</topic><topic>ISOMERIC TRANSITION ISOTOPES</topic><topic>ISOTOPES</topic><topic>LEUKOPENIA</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>MALE GENITALS</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>MINUTES LIVING RADIOISOTOPES</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Neoplasm Staging</topic><topic>NEOPLASMS</topic><topic>NUCLEAR MEDICINE</topic><topic>NUCLEI</topic><topic>ODD-ODD NUCLEI</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</topic><topic>RADIATIONS</topic><topic>RADIOINDUCTION</topic><topic>RADIOISOTOPES</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOTHERAPY</topic><topic>Radiotherapy Dosage</topic><topic>Random Allocation</topic><topic>SIDE EFFECTS</topic><topic>TESTES</topic><topic>Testicular Neoplasms - mortality</topic><topic>Testicular Neoplasms - pathology</topic><topic>Testicular Neoplasms - therapy</topic><topic>Testis cancer</topic><topic>THERAPY</topic><topic>Time Factors</topic><topic>Tumors</topic><topic>United States</topic><topic>Vinblastine - administration &amp; dosage</topic><topic>X RADIATION</topic><topic>YEARS LIVING RADIOISOTOPES</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stephens, Ronald L.</creatorcontrib><creatorcontrib>Eltringham, James R.</creatorcontrib><creatorcontrib>Coltman, Charles A.</creatorcontrib><creatorcontrib>Neidhart, James</creatorcontrib><creatorcontrib>Mullins, James</creatorcontrib><creatorcontrib>Frank, Jess</creatorcontrib><creatorcontrib>Univ. of Kansas, Kansas City</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Int. J. Radiat. Oncol., Biol. Phys.; (United States)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stephens, Ronald L.</au><au>Eltringham, James R.</au><au>Coltman, Charles A.</au><au>Neidhart, James</au><au>Mullins, James</au><au>Frank, Jess</au><aucorp>Univ. of Kansas, Kansas City</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer</atitle><jtitle>Int. J. Radiat. Oncol., Biol. Phys.; (United States)</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>1983-12</date><risdate>1983</risdate><volume>9</volume><issue>12</issue><spage>1885</spage><epage>1890</epage><pages>1885-1890</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>During a two year period, 65 patients with Stage II non-seminomatous testis cancer were randomized to receive adjuvant chemotherapy and radiation. Of the 52 evaluable patients, 23 received radiation followed by chemotherapy (sequential), and 29 received the same chemotherapy as initial treatment, but had drug treatment temporarily interrupted for radiation (sandwich). The combined treatment was well tolerated, but did not eliminate recurrence. With regard to duration of survival and disease-free survival, no statistically significant difference could be found between the sequential and sandwich approaches.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>6198313</pmid><doi>10.1016/0360-3016(83)90357-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof Int. J. Radiat. Oncol., Biol. Phys.; (United States), 1983-12, Vol.9 (12), p.1885-1890
issn 0360-3016
1879-355X
language eng
recordid cdi_proquest_miscellaneous_80848182
source MEDLINE; Elsevier ScienceDirect Journals
subjects 550603 - Medicine- External Radiation in Therapy- (1980-)
560151 - Radiation Effects on Animals- Man
Adjuvant treatment
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
Biological and medical sciences
Bleomycin - administration & dosage
BODY
CHEMOTHERAPY
COBALT 60
COBALT ISOTOPES
Combined Modality Therapy
DISEASES
ELECTROMAGNETIC RADIATION
GAMMA RADIATION
GONADS
Gynecology. Andrology. Obstetrics
HARD X RADIATION
HEMIC DISEASES
Humans
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IONIZING RADIATIONS
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LEUKOPENIA
Male
Male genital diseases
MALE GENITALS
Medical sciences
MEDICINE
Middle Aged
MINUTES LIVING RADIOISOTOPES
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - therapy
Neoplasm Staging
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
PATIENTS
RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT
RADIATIONS
RADIOINDUCTION
RADIOISOTOPES
RADIOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
RADIOTHERAPY
Radiotherapy Dosage
Random Allocation
SIDE EFFECTS
TESTES
Testicular Neoplasms - mortality
Testicular Neoplasms - pathology
Testicular Neoplasms - therapy
Testis cancer
THERAPY
Time Factors
Tumors
United States
Vinblastine - administration & dosage
X RADIATION
YEARS LIVING RADIOISOTOPES
title The southwest oncology group experience: adjuvant therapy for stage IB and II non-seminomatous testicular cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T06%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20southwest%20oncology%20group%20experience:%20adjuvant%20therapy%20for%20stage%20IB%20and%20II%20non-seminomatous%20testicular%20cancer&rft.jtitle=Int.%20J.%20Radiat.%20Oncol.,%20Biol.%20Phys.;%20(United%20States)&rft.au=Stephens,%20Ronald%20L.&rft.aucorp=Univ.%20of%20Kansas,%20Kansas%20City&rft.date=1983-12&rft.volume=9&rft.issue=12&rft.spage=1885&rft.epage=1890&rft.pages=1885-1890&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/0360-3016(83)90357-7&rft_dat=%3Cproquest_osti_%3E80848182%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80848182&rft_id=info:pmid/6198313&rft_els_id=0360301683903577&rfr_iscdi=true